Anna Dudakova

498 total citations
9 papers, 202 citations indexed

About

Anna Dudakova is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Anna Dudakova has authored 9 papers receiving a total of 202 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 5 papers in Epidemiology and 3 papers in Clinical Biochemistry. Recurrent topics in Anna Dudakova's work include Antifungal resistance and susceptibility (4 papers), Bacterial Identification and Susceptibility Testing (3 papers) and Fungal Infections and Studies (3 papers). Anna Dudakova is often cited by papers focused on Antifungal resistance and susceptibility (4 papers), Bacterial Identification and Susceptibility Testing (3 papers) and Fungal Infections and Studies (3 papers). Anna Dudakova collaborates with scholars based in Germany, Thailand and Hungary. Anna Dudakova's co-authors include Uwe Groß, Michael Weig, Oliver Bader, Marut Tangwattanachuleeporn, Jana Tünnermann, Birgit Spieß, Christoph Sasse, Dieter Buchheidt, Jesse R. Willis and Marco H. Schulze and has published in prestigious journals such as Clinical Microbiology Reviews, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology.

In The Last Decade

Anna Dudakova

8 papers receiving 201 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Dudakova Germany 6 162 105 59 43 31 9 202
Mohammad T. Albataineh United States 9 193 1.2× 190 1.8× 61 1.0× 44 1.0× 23 0.7× 13 362
Eta E. Ashu Canada 9 160 1.0× 92 0.9× 90 1.5× 84 2.0× 23 0.7× 12 266
Agustin Reséndiz-Sharpe Belgium 11 291 1.8× 215 2.0× 88 1.5× 56 1.3× 42 1.4× 22 338
Luzia Lyra Brazil 11 236 1.5× 184 1.8× 101 1.7× 59 1.4× 37 1.2× 20 314
M. Palous France 8 222 1.4× 202 1.9× 76 1.3× 26 0.6× 32 1.0× 9 305
Natalie S. Nunnally United States 10 291 1.8× 198 1.9× 59 1.0× 31 0.7× 26 0.8× 15 340
Radim Dobiáš Czechia 10 104 0.6× 140 1.3× 84 1.4× 32 0.7× 35 1.1× 29 223
Josef Kaltseis Austria 6 143 0.9× 80 0.8× 83 1.4× 63 1.5× 29 0.9× 6 212
Thanwa Wongsuk Thailand 7 143 0.9× 91 0.9× 42 0.7× 56 1.3× 9 0.3× 22 271
Marcela Guevara‐Suarez Colombia 10 87 0.5× 61 0.6× 140 2.4× 121 2.8× 13 0.4× 19 255

Countries citing papers authored by Anna Dudakova

Since Specialization
Citations

This map shows the geographic impact of Anna Dudakova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Dudakova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Dudakova more than expected).

Fields of papers citing papers by Anna Dudakova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Dudakova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Dudakova. The network helps show where Anna Dudakova may publish in the future.

Co-authorship network of co-authors of Anna Dudakova

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Dudakova. A scholar is included among the top collaborators of Anna Dudakova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Dudakova. Anna Dudakova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Streit, Frank, Christian Schumann, Anna Dudakova, et al.. (2023). Feasibility of Continuous Infusion of Cefiderocol in Conjunction with the Establishment of Therapeutic Drug Monitoring in Patients with Extensively Drug-Resistant Gram-Negative Bacteria. Clinical Drug Investigation. 43(4). 307–314. 5 indexed citations
2.
Kaase, Martin, et al.. (2023). Central venous catheter contamination rate in suspected sepsis patients: an observational clinical study. Journal of Hospital Infection. 135. 98–105. 3 indexed citations
4.
Schulze, Marco H., et al.. (2022). Bacterial Spectrum and Infective Foci in Patients Operated for Infective Endocarditis: Time to Rethink Strategies?. The Thoracic and Cardiovascular Surgeon. 71(1). 2–11. 1 indexed citations
5.
Perl, Thorsten, et al.. (2022). Blood Culture Headspace Gas Analysis Enables Early Detection of Escherichia coli Bacteremia in an Animal Model of Sepsis. Antibiotics. 11(8). 992–992. 10 indexed citations
6.
Willis, Jesse R., Anna Dudakova, Laia Carreté, et al.. (2020). Phenotypic Variability in a Coinfection With Three Independent Candida parapsilosis Lineages. Frontiers in Microbiology. 11. 1994–1994. 14 indexed citations
7.
Dudakova, Anna & Marco H. Schulze. (2020). Präanalytik: Blutkultur, Urin, Stuhl. 14(4). 347–365.
8.
Dudakova, Anna, Birgit Spieß, Marut Tangwattanachuleeporn, et al.. (2017). Molecular Tools for the Detection and Deduction of Azole Antifungal Drug Resistance Phenotypes in Aspergillus Species. Clinical Microbiology Reviews. 30(4). 1065–1091. 84 indexed citations
9.
Bader, Oliver, Jana Tünnermann, Anna Dudakova, et al.. (2015). Environmental Isolates of Azole-Resistant Aspergillus fumigatus in Germany. Antimicrobial Agents and Chemotherapy. 59(7). 4356–4359. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026